How much funding has PULMOTECT, INC raised?

PULMOTECT, INC has raised $32.0M in total funding, most recently a Series C round.

When was PULMOTECT, INC founded?

PULMOTECT, INC was founded in 2015.

Where is PULMOTECT, INC headquartered?

PULMOTECT, INC is headquartered in Houston, Texas, United States.

What industry is PULMOTECT, INC in?

PULMOTECT, INC operates in Biotech, Healthcare.

How many employees does PULMOTECT, INC have?

PULMOTECT, INC has 1-10 employees.

PULMOTECT, INC

Q: Who are PULMOTECT, INC's investors?

PULMOTECT, INC's investors include Cancer Prevention and Research Institute of Texas, Fannin Partners LP (internal fund), U.S. Department of Defense.

Harnessing the Power of the Innate Immune System

Houston, United States · Founded 2015 · $32.0M raised

Biotech

Healthcare

Headquarters: Houston, Texas
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: pulmotect.com
Total Funding: $32.0M
Last Round: $5.9M Series CSep 2024
Rounds: 6

About

Pulmotect is a clinical-stage biopharmaceutical company harnessing the innate immune system to prevent and treat respiratory infections. Its lead product, PUL-042, is an inhaled therapeutic that activates lung innate immunity, protecting against bacterial, fungal, and viral pathogens, with a focus on immunocompromised oncology patients.

Summary

PULMOTECT, INC is a Biotech company based in Houston, United States, founded in 2015. It has raised $32.0M in total across 6 rounds, most recently a $5.9M Series C round in Sep 2024. Investors include Cancer Prevention and Research Institute of Texas, Fannin Partners LP (internal fund) and U.S. Department of Defense.

LinkedIn X (Twitter)